Диссертация (1141045), страница 21
Текст из файла (страница 21)
Shang, B. Yuan, C. Han, Y. Wang //The Journal of reproductive medicine. - 2016. - Т. 61, № 5–6. - P. 282–286.100. Liu, J. Acute Fatty Liver Disease of Pregnancy: Updates inPathogenesis, Diagnosis, and Management / J. Liu, T.T. Ghaziani, J.L. Wolf// The American Journal of Gastroenterology. - 2017. - T.112, №6. - P.838.129101. Liu,S.Epidemiologyofpregnancy-associatedvenousthromboembolism: a population-based study in Canada / S. Liu, J. Rouleau,K.S. Joseph, R. Sauve, R.M. Liston, D.
Young, M.S. Kramer // Journal ofObstetrics Gynaecology Canada. - 2009. - Т. 31, № 7. - P. 611–620.100. Mackillop, L. Liver disease in pregnancy / L. Mackillop, C.Williamson // Postgraduate medical journal. - 2010. - Т. 86, № 1013. - P.160–164.101. Madsen, L.R. Rhabdomyolysis caused by hyperemesis gravidarum /L.R. Madsen, M . Søgaard // Ugeskrift for laeger. - 2017.
- Т. 179, № 9. P.217-223.102. Menzies, J. Current CHS and NHBPEP Criteria for SeverePreeclampsia Do Not Uniformly Predict Adverse Maternal or PerinatalOutcomes / J. Menzies, L.A. Magee, Y.C. Macnab, J.M. Ansermino, J. Li,M.J. Douglas, J.M. Moutquin // Hypertension in pregnancy. - 2007. - Т. 26,№ 4. - P. 447–462.103. Mihu, D. HELLP syndrome - a multisystemic disorder / D. Mihu, N.Costin, C.M. Mihu, A. Seicean, R. Ciortea // Journal of Gastrointestinal andLiver Diseases.
- 2007. - Т. 16, № 4. P. 419–424.104. Mishra, N. Study of Abnormal Liver Function Test during Pregnancyin a Tertiary Care Hospital in Chhattisgarh / N. Mishra, V.N. Mishra, P.Thakur // Journal Obstetrocs and. Gynecology of India. - 2016. -Т. 66, № 1.P. 129–135.105. Mitchell, S.J. ECG changes in hyperemesis gravidarum / S.J. Mitchell,P. Cox // BMJ case reports. - 2017.
- Т. 2017. - P.217-234.106. Monga, M. Acute fatty liver in the second trimester / M. Monga, A.R.Katz // Obstetrics & Gynecology. - 1999. - Т. 93, № 5. - P. 811–813.107. Morgan, S.R. Are early pregnancy complications more common inwomen with hyperemesis gravidarum? / S.R. Morgan, L.Long, J. Johns, C.Angwin, S. Maitra, J.A. Ross // Journal of Obstetrics and Gynaecology. 2017. - Т. 37, № 3. - P.
355–357.130108.Obrowski, M. Hyperemesis Gravidarum–A Serious Issue duringPregnancy: In-Depth Clinical Review and Treatment Modalities / M.Obrowski, S. Obrowski // MOJ Womens Health. - 2015. - Т. 1, № 2 - P.1016.109. Oppenraaij, R.H.F. van. Predicting adverse obstetric outcome afterearly pregnancy events and complications: a review / R.H.F. van Oppenraaij,E. Jauniaux, O.B. Christiansen, J.A. Horcajadas, R.G. Farquharson, N.Exalto // Human reproduction update. - 2009. - Т.
15, № 4. - P. 409–421.110.Pandey, C.K. Acute liver failure in pregnancy: Challenges andmanagement / C.K. Pandey, S.T. Karma, V.K. Pandey, M. Tandon // Indianjournal of anaesthesia. - 2015. - Т. 59, № 3. - P. 144.111.Perez, M.J. Maternal cholestasis induces placental oxidative stressand apoptosis. Protective effect of ursodeoxycholic acid / M.J. Perez, R.I.R.Macias, J.J.G. Marin // Placenta. - 2006. - Т.
27, № 1. - P. 34–41.112. Pusl, T. Intrahepatic cholestasis of pregnancy / T. Pusl, U. Beuers //Orphanet journal of rare diseases. - 2007. - Т. 2, №1. - P. 26.113. Reyes, H. Acute fatty liver of pregnancy: a clinical study of 12episodes in 11 patients / H. Reyes, L. Sandoval, A. Wainstain, J. Ribalta, S.Donoso, G.
Smok, M. Meneses // Gut.- 1994. - Т. 35, № 1. - С. 101–10 6.114.Sandven, I. Helicobacter pylori infection and hyperemesisgravidarum: a systematic review and meta-analysis of case-control studies /I. Sandven, M. Abdeelnoor, B.I. Nesheim, K.K. Melby // Acta obstetricia etgynecologic Scandinavica. - 2009.
- Т. 88, № 11. - P. 1190–1200.115. Schneider, G. Linkage between a new splicing site mutation in theMDR3 alias ABCB4 gene and intrahepatic cholestasis of pregnancy / G.Schneider, T.C. Paus, G.A. Kullak-Ublick, P.J. Meier, T.F. Wienker, T.Lang, C. Reichel // Hepatology.
- 2007. - Т. 45, № 1. - P. 150–158.116.Shekhawat, P. Human placenta metabolizes fatty acids: implicationsfor fetal fatty acid oxidation disorders and maternal liver diseases / P.Shekhawat, M.J. Bennett, Y. Sadovsky, D.M. Nelson, D. Rakheja, A.W.131Strauss // American Journal of Physiology- Endocrinology and Metabolism.- 2003. - Т. 284, № 6. - P. E1098-1105.117. Stasi, C. Non-invasive assessment of liver fibrosis: Betweenprediction/prevention of outcomes and cost-effectiveness / C. Stasi, S.Milani // World journal of gastroenterology. - 2016. - Т. 22. - № 4. - P.1711–1720.118.
Tran, T.T. Corrigendum: ACG Clinical Guideline: Liver Disease andPregnancy / T.T. Tran, J. Ahn, N.S. Reau // The American journal ofgastroenterology - 2016. - Т. 111, № 11. - P. 1668119. Tuffnell, D.J. Outcomes of severe pre-eclampsia/eclampsia inYorkshire 1999/2003 / D.J. Tuffnell, D. Jankowicz, S.W. Lindow, G. Lyons,G.C. Mason, I.F. Russell, J.J. Walker // BJOG An International Journal ofObsterrics & Gynaecology. - 2005. - Т. 112, № 7.
- P. 875–880.120. Gracia, V.D. Acute fatty liver and HELLP syndrome: two distinctpregnancy disorders / V.D Gracia // International Journal of Gynaecology &Obstetrics. - 2001. - Т. 73, № 3. - P. 215–220.121. Wai, C.T. A simple noninvasive index can predict both significantfibrosis and cirrhosis in patients with chronic hepatitis C / C.T.
Wai, J.K.Greenson, R.J. Fontana, J.D. Kalbfleisch, J.A. Marrero, H.S. Conjeevaram,A.S.F. Lok // Hepatology. - 2003. - Т. 38, № 2. - P. 518–526.122. Wang, S. Noninvasive Swansea criteria are valuable alternatives fordiagnosing acute fatty liver of pregnancy in a Chinese population / S. Wang,S.L. Li, Y.X.
Cao, Y.P. Li, J.L. Meng, X.T. Wang // The Journal ofMaternal-Fetal & Neonatal Medicine - 2017. - T.30, №24. - P. 2951-2955.123.Wei, Q. Clinical diagnosis and treatment of acute fatty liver ofpregnancy: A literature review and 11 new cases / Q. Wei, L. Zhang, X. Liu// Journal of Obstetrics and Gynaecology Research - 2010. - Т. 36, № 4. P.
751–756.124.Weinstein, L. Syndrome of hemolysis, elevated liver enzymes, andlow platelet count: a severe consequence of hypertension in pregnancy / L.132Weinstein // American Journal of obstetrics and gynecology - 1982. - P.142, № 2. - С. 159–167.125. Westbrook, R.H. Pregnancy and liver disease / R.H. Westbrook, G.Dusheiko, C. Williamson // Journal of hepatology - 2016. - Т. 64, № 4. - P.933–945.126.
Williamson, C. The bile acid taurocholate impairs rat cardiomyocytefunction: a proposed mechanism for intra-uterine fetal death in obstetriccholestasis / C.Williamson, J. Gorelik, B.M. Eaton, M. de Swiet, Y. Korchev// Clin. Science. - 2001. - Т. 100, № 4. - P. 363–369.127.Zapata, R. Ursodeoxycholic acid in the treatment of intrahepaticcholestasis of pregnancy. A 12-year experience / R. Zapata, L.
Sandoval, J.Palma, I. Hernandez, J. Ribalta, H. Reyes, J.J. Silva // Liver International. 2005. - Т. 25, № 3. - P. 548–554.128. Zarrinpar, A. Liver transplantation for HELLP syndrome / A.Zarrinpar, D.G. Farmer, R.M. Ghobrial, G.S. Lipshutz, Y. Gu, J.R. Hiatt,R.W. Busuttil // The American Surgeon. - 2007. - Т. 73, № 10.
- P. 1013–1016.Приложение АТаблица А-1.Балльная система оценки степени нарушения функции печени у беременныхСтепень нарушенияфункции печениОтсутствиенарушенийфункциипечени(0-4%)БаллыНезначительныенарушения(снижениефункции на 524%)БаллыУмеренныенарушенияфункциипечени(снижениефункции на 2549%)БаллыТяжелыенарушенияфункциипечени(снижениефункции на 5095%)БаллыАбсолютныенарушенияфункциипечени(снижениефункции на 95100%)Баллы≤38≤404445-7440-603375-14960-12022150-299120-25011≥300≥2500065-85455-65350-55245-501≤4508-20420-25325-40240-801≥8002,8-7,542,5-2,832,0-2,521,7-2,01≤1,703,1-5,543,4-3,933,9-4,524,6-91≥90До 2204220-2403240-4502450-9001900≥03,5-5,543,0-3,532,5-3,022,0-2,51≤2,502-441,8-231,6-1,821,4-1,61≤1,4070-120%465-70360-65255-601≤550БиохимическиепоказателиАЛТ Eд/лАСТ Ед/л133Общий белокг/лОбщийбилирубинммолль/лМочевинаХолестеринммоль/лЩФ Ед/лГлюкозаммоль/лФибриноген г/лПротромбин поКвику, %134Приложение ВТаблица В-1.Балльная шкала оценки степени нарушения функции печениСтепень нарушения функциипечениОтсутствие нарушений функциипечениСумма баллов38-40 балловНезначительные нарушенияфункции печени (снижение30-37 балловфункции на 5-24%)Умеренные нарушения функциипечени (снижение функции на20-29 баллов25-49%)Тяжелые нарушения функциипечени (снижение функции на3-19 баллов50-95%)Абсолютные нарушенияфункции печени (снижениефункции на 96-100%)0-2 балла.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
